IBDEI0SU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13524,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,13524,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,13525,0)
 ;;=C79.51^^53^593^113
 ;;^UTILITY(U,$J,358.3,13525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13525,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,13525,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,13525,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,13526,0)
 ;;=C79.52^^53^593^112
 ;;^UTILITY(U,$J,358.3,13526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13526,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,13526,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,13526,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,13527,0)
 ;;=C79.31^^53^593^114
 ;;^UTILITY(U,$J,358.3,13527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13527,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,13527,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,13527,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,13528,0)
 ;;=C79.72^^53^593^129
 ;;^UTILITY(U,$J,358.3,13528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13528,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,13528,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,13528,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,13529,0)
 ;;=C78.02^^53^593^133
 ;;^UTILITY(U,$J,358.3,13529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13529,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,13529,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,13529,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,13530,0)
 ;;=C78.7^^53^593^138
 ;;^UTILITY(U,$J,358.3,13530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13530,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,13530,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,13530,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,13531,0)
 ;;=C79.71^^53^593^151
 ;;^UTILITY(U,$J,358.3,13531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13531,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,13531,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,13531,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,13532,0)
 ;;=C78.01^^53^593^155
 ;;^UTILITY(U,$J,358.3,13532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13532,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,13532,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,13532,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,13533,0)
 ;;=C79.70^^53^593^106
 ;;^UTILITY(U,$J,358.3,13533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13533,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,13533,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,13533,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,13534,0)
 ;;=C78.00^^53^593^139
 ;;^UTILITY(U,$J,358.3,13534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13534,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,13534,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,13534,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,13535,0)
 ;;=D57.1^^53^593^182
 ;;^UTILITY(U,$J,358.3,13535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13535,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,13535,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,13535,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,13536,0)
 ;;=D75.1^^53^593^180
 ;;^UTILITY(U,$J,358.3,13536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13536,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,13536,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,13536,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,13537,0)
 ;;=C90.30^^53^593^183
 ;;^UTILITY(U,$J,358.3,13537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13537,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
